Want to track CTMX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
CytomX Therapeutics Inc. (CTMX) Statistics
Valuation metrics
Market Cap 807.68M
Enterprise value 796.16M
Trailing P/E (ttm) -8.24
Forward P/E -10.06
PEG ratio 0.06
Price/Sales (ttm) 44.13
Price/Book (mrq) 2.69
Enterprise Value/Revenue 43.5
Enterprise Value/EBITDA -10.18
Overview
Shares outstanding 170.19M
Float 139.4M
Shares short 22.03M
% Held by insiders 0.01%
% Held by institutions 0.76%
Average volume (10 days) 4.08M
Average volume (90 days) 5.37M
Price summary
52-Week low 1.9
52-Week high 8.21
Beta 2.48
50-Day moving average 3.46
200-Day moving average 4.29
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin -4.35%
Operating margin -4.76%
Operational effectiveness
Return on assets -0.21%
Return on equity -0.38%
Income Statement
Revenue (ttm) 76.2M
Revenue per share (ttm) 0.08
Quarterly revenue growth (yoy) -0.98%
Gross profit (ttm) 76.2M
EBITDA -18.19M
Net income to common (ttm) -20.37M
Diluted EPS (ttm) -0.36
Quarterly earnings growth (yoy) -0.98%
Balance Sheet
Total cash (mrq) 137.05M
Total cash per share (mrq) 1.51
Total debt (mrq) 4.24M
Total Debt/Equity (mrq) 0.02
Current ratio (mrq) 9.36%
Book value per share (mrq) 1.38
Cash Flow
Cash flow statement -75.59M
Levered free cash flow (LFCF) -43.21M
